Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anti-VEGF”

489 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 489 results

Testing effectiveness (Phase 2)Study completedNCT02140151
What this trial is testing

Prophylactic Ranibizumab for Exudative Age-related Macular Degeneration

Who this might be right for
Age-related Macular Degeneration
Southern California Desert Retina Consultants, MC 108
Early research (Phase 1)UnknownNCT04151407
What this trial is testing

The Study of Drug 601 in Patients With Diabetic Macular Edema (DME)

Who this might be right for
Diabetic Macular Edema
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 50
Testing effectiveness (Phase 2)Study completedNCT01159171
What this trial is testing

Avastin (Bevacizumab) and Oxaliplatin Plus Xeloda (Capecitabine) in Patients With Advanced Colorectal Cancer.

Who this might be right for
Colorectal Cancer
Hoffmann-La Roche 50
Testing effectiveness (Phase 2)Ended earlyNCT02214628
What this trial is testing

Phase 2A Open Label Safety Study of Fovista® (Anti-PDGF BB) Regimen Administered in Combination With Anti-VEGF Therapy to Study Sub-Retinal Fibrosis in Neovascular AMD

Who this might be right for
Age-related Macular Degeneration
Ophthotech Corporation 101
Testing effectiveness (Phase 2)Study completedNCT00109057
What this trial is testing

An Extension Study to Evaluate Avastin in Patients Treated in a Previous Genentech-Sponsored Cancer Study

Who this might be right for
Cancer
Genentech, Inc. 56
Post-approval studies (Phase 4)Not Yet RecruitingNCT07187804
What this trial is testing

Long Term Efficacy of Faricimab Using a Treat and Extend Regimen for Type 3 Macular Neovascularization

Who this might be right for
Age-related Macular Degeneration (ARMD)Choroidal NeovascularizationAnti-vascular Endothelial Growth Factor
Kim's Eye Hospital 30
Post-approval studies (Phase 4)Study completedNCT01500915
What this trial is testing

FUSION Regimen: Combined Pro re Nata and Fixed Regimen Ranibizumab in Exudative Age-related Macular Degeneration

Who this might be right for
Exudative Age-related Macular Degeneration
Institut de la Macula y la Retina 17
Not applicableStudy completedNCT05003258
What this trial is testing

Functional and Anatomical Outcomes of Dexamethasone Intra-vitreal Implant in Patients with Resistant Macular Edema Secondary to Retinal Vein Occlusion After Intravitreal Anti-VEGF Injection

Who this might be right for
Macular EdemaRetinal Vein Occlusion
Assiut University 25
Large-scale testing (Phase 3)Study completedNCT00312377
What this trial is testing

ZACTIMA (an Anti-EGFR / Anti-VEGF Agent) Combined With Docetaxel Compared to Docetaxel in Non-small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung CancerLung Cancer
Genzyme, a Sanofi Company 1,690
Not applicableStudy completedNCT03345667
What this trial is testing

Assessment of Color Vision in Diabetic Patients

Who this might be right for
Retinopathy, Diabetic
Instituto de Olhos de Goiania 30
Early research (Phase 1)Study completedNCT01015222
What this trial is testing

Dasatinib, Bevacizumab, Paclitaxel in Patients With Advanced Malignancies

Who this might be right for
Advanced Cancer
M.D. Anderson Cancer Center 122
Large-scale testing (Phase 3)WithdrawnNCT03784443
What this trial is testing

Combined Ranibizumab and Iluvien for Diabetic Macular Oedema

Who this might be right for
Diabetic Macular EdemaDiabetes
Imperial College London
Testing effectiveness (Phase 2)Study completedNCT04172571
What this trial is testing

The Combination of Anti-PD-1 AK105 and Anlotinib in First-line Hepatocellular Carcinoma (HCC)

Who this might be right for
Hepatocellular Carcinoma
Akeso 31
Testing effectiveness (Phase 2)Study completedNCT02303184
What this trial is testing

Suprachoroidal Injection of Triamcinolone Acetonide With IVT Aflibercept in Subjects With Macular Edema Following RVO

Who this might be right for
Macular EdemaRetinal Vein Occlusion
Clearside Biomedical, Inc. 46
Not applicableStudy completedNCT07514559
What this trial is testing

Comparison of Intravitreal Anti-VEGF Treatment Burden in Different Retinal Diseases

Who this might be right for
Age Related Macular Degeneration (ARMD)Retinal Vein Occlusion (RVO)Diabetic Macular Edema (DME)
Hospital Hietzing 393
Not applicableStudy completedNCT01447043
What this trial is testing

Study to Assess the Effectiveness of Existing Anti vascUlar Endothelial Growth Factor (Anti VEGF) in Patients With Wet Age-related Macular Degeneration (wAMD) (AURA)

Who this might be right for
Ophthalmology, Macular Degeneration
Bayer 2,609
Testing effectiveness (Phase 2)Ended earlyNCT00023920
What this trial is testing

Bevacizumab, Idarubicin, and Cytarabine in Treating Patients With Blast Phase Chronic Myelogenous Leukemia

Who this might be right for
Blastic Phase Chronic Myelogenous LeukemiaChronic Myelogenous Leukemia, BCR-ABL1 Positive
National Cancer Institute (NCI) 60
Not applicableLooking for participantsNCT05717738
What this trial is testing

Combined TACE, TKI/Anti-VEGF and ICIs as Conversion Therapy for Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma Non-resectable
Tongji Hospital 300
Not applicableStudy completedNCT02541084
What this trial is testing

Caregiver Burden of Wet Age-related Macular Degeneration (wAMD) in Japan

Who this might be right for
Wet Macular Degeneration
Bayer 72
Large-scale testing (Phase 3)Active Not RecruitingNCT06556368
What this trial is testing

Evaluate the Efficacy and Safety of Tarcocimab Tedromer and Tabirafusp Tedromer Compared to Aflibercept in Participants With Neovascular (Wet) Age-related Macular Degeneration (wAMD) - DAYBREAK

Who this might be right for
Wet Age-related Macular Degeneration
Kodiak Sciences Inc 675
Load More Results